1.
Ned Tijdschr Geneeskd
; 146(8): 390-1; author reply 391, 2002 Feb 23.
Artigo
em Holandês
| MEDLINE
| ID: mdl-11887631
Assuntos
Distocia/terapia , Vácuo-Extração/efeitos adversos , Feminino , Humanos , Recém-Nascido , Gravidez , Fatores de Risco
2.
Ned Tijdschr Geneeskd
; 145(42): 2054-5; author reply 2055-6, 2001 Oct 20.
Artigo
em Holandês
| MEDLINE
| ID: mdl-11695107
3.
Int J Androl
; 6(2): 173-9, 1983 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-6553021
RESUMO
Nineteen men with asthenozoospermia were treated with oral Kallikrein (600 U daily for 12 weeks) and sperm motility evaluated in 16 of these patients. No quantitative or qualitative improvement motility or the duration of motility was found in semen samples examined 4, 12, and 24 weeks after starting the treatment. Two pregnancies occurred 11 and 40 weeks after discontinuation of the Kallikrein therapy.